Table 1.

List of webinar presentations held prior to the workshop.

	Speaker	Affiliation	Title
Webinar 1	Dr. Pilar Prieto	European Union Reference Laboratory for Alternatives to Animal Testing	EURL ECVAM’s strategy to replace, reduce, and refine the use of animals in the assessment of acute mammalian systemic toxicity and an industry perspective
	Dr. Lawrence Milchak	3M Company
Webinar 2	Dr. Stefan Schulz	Helmholtz Center for Environmental Research	High-throughput models and zebrafish embryos as alternatives to assess acute systemic toxicity
	Dr. Daniel Wilson	The Dow Chemical Company
Webinar 3	Dr. Michael Bolger	Simulations Plus	Estimation of acute toxicity using in vitro to in vivo extrapolation; acute oral toxicity modeling
	Dr. Ann Detroyer	L’Oréal	Acute oral toxicity modeling accounting for mechanism and toxicological mode of action
Webinar 4	Dr. Anna Forsby	Stockholm University and Swedish Toxicology Sciences Research Center (Swetox)	Neuronal specific modes of action of acute systemic toxicity
Webinar 5	Dr. Stephen Ferguson	National Institute of Environmental Health Sciences	Tox21 phase III: in vitro and in silico approaches to predict xenobiotic metabolism and toxicity potential
	Dr. Harvey Clewell	The Hamner Institutes for Health Sciences	Extrapolation of in vitro toxicity assay results to provide information regarding acute in vitro exposures
Webinar 6	Mr. John Redden	U.S. EPA	How the U.S. EPA Pesticide Program uses inhalation toxicity studies
	Dr. Patrick Hayden	MatTek Corporation	Use of EpiAirway™ organotypic human airway models and assay methods for in vitro inhalation toxicology screening
	Dr. Samuel Constant	Epithelix Sàrl	The use of human airway tissue-based assays (MucilAir™) for acute toxicity assessment